메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages

MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR; BIOLOGICAL MARKER; HGF PROTEIN, HUMAN; MET PROTEIN, HUMAN;

EID: 84926683147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120079     Document Type: Article
Times cited : (18)

References (46)
  • 2
    • 84892805731 scopus 로고    scopus 로고
    • Cancer statistics, 2014
    • 24399786
    • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014. 64:9-29. doi: 10. 3322/caac.21208 PMID: 24399786
    • (2014) CA Cancer J Clin. , vol.64 , pp. 9-29
    • Siegel, R.1    Ma, J.2    Zou, Z.3    Jemal, A.4
  • 4
    • 66549092182 scopus 로고    scopus 로고
    • Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • Casali PG, Jost L, Sleijfer S, Verweij J, Blay J-Y, Group Obot EGW. Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009. 20: iv132-iv136.
    • (2009) Ann Oncol. , vol.20 , pp. iv132-iv136
    • Casali, P.G.1    Jost, L.2    Sleijfer, S.3    Verweij, J.4    Blay, J.-Y.5
  • 5
    • 84884206527 scopus 로고    scopus 로고
    • Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma
    • 22984679
    • Lee HJ, Song SY, Kwon T-W, Yook JH, Kim S-C, Han D-J, et al. Treatment outcome of postoperative radiotherapy for retroperitoneal sarcoma. Radiat Oncol J. 2011. 29:260-268. doi: 10.3857/roj.2011. 29.4.260 PMID: 22984679
    • (2011) Radiat Oncol J. , vol.29 , pp. 260-268
    • Lee, H.J.1    Song, S.Y.2    Kwon, T.-W.3    Yook, J.H.4    Kim, S.-C.5    Han, D.-J.6
  • 6
    • 84867547132 scopus 로고    scopus 로고
    • Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma
    • 22984684
    • Lee J, Park YJ, Yang DS, Yoon WS, Lee JA, Rim CH, et al. Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma. Radiat Oncol J. 2012. 30:62-69. doi: 10.3857/roj.2012.30.2.62 PMID: 22984684
    • (2012) Radiat Oncol J. , vol.30 , pp. 62-69
    • Lee, J.1    Park, Y.J.2    Yang, D.S.3    Yoon, W.S.4    Lee, J.A.5    Rim, C.H.6
  • 7
    • 0022387730 scopus 로고
    • The human met oncogene is related to the tyrosine kinase oncogenes
    • 4069211
    • Dean M, Park M, Le Beau MM, Robins TS, Diaz MO, Rowley JD, et al. The human met oncogene is related to the tyrosine kinase oncogenes. Nature. 1985. 318:385-388. PMID: 4069211
    • (1985) Nature. , vol.318 , pp. 385-388
    • Dean, M.1    Park, M.2    Le Beau, M.M.3    Robins, T.S.4    Diaz, M.O.5    Rowley, J.D.6
  • 8
    • 0023661693 scopus 로고
    • Scatterfactor is a fibroblast-derived modulator of epithelial cell mobility
    • 2952888
    • Stoker M, Gherardi E, Perryman Mand Gray J. Scatterfactor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987. 327:239-242. PMID: 2952888
    • (1987) Nature. , vol.327 , pp. 239-242
    • Stoker, M.1    Gherardi, E.2    Perryman Mand Gray, J.3
  • 9
    • 0025771101 scopus 로고
    • Scatter factor and hepatocyte growth factor are indistinguishable ligandsforthe MET receptor
    • 1655405
    • Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligandsforthe MET receptor. EMBO J. 1991. 10:2867-2878. PMID: 1655405
    • (1991) EMBO J. , vol.10 , pp. 2867-2878
    • Naldini, L.1    Weidner, K.M.2    Vigna, E.3    Gaudino, G.4    Bardelli, A.5    Ponzetto, C.6
  • 10
    • 0025136830 scopus 로고
    • Quantitation of cytokine-stimulated migration of endothelium and epithelium by a new assay using microcarrier beads
    • 2137088
    • Rosen EM, Meromsky L, Setter E, Vinter DW, Goldberg ID. Quantitation of cytokine-stimulated migration of endothelium and epithelium by a new assay using microcarrier beads. Exp Cell Res. 1990. 186:22-31. PMID: 2137088
    • (1990) Exp Cell Res. , vol.186 , pp. 22-31
    • Rosen, E.M.1    Meromsky, L.2    Setter, E.3    Vinter, D.W.4    Goldberg, I.D.5
  • 11
  • 12
    • 84555202728 scopus 로고    scopus 로고
    • MET signaling pathway: A rational target for cancer therapy
    • 22042966
    • Appleman LJ. MET Signaling Pathway: A Rational Target for Cancer Therapy. J Clin Oncol. 2011. 29:4837-4838. doi: 10.1200/JCO.2011.37.7929 PMID: 22042966
    • (2011) J Clin Oncol. , vol.29 , pp. 4837-4838
    • Appleman, L.J.1
  • 13
    • 0028270761 scopus 로고
    • Scatterfactor modulates the metastatic phenotype of the EMT6 mouse mammary tumor
    • 8194880
    • Rosen EM, Knesel J, Goldberg ID, Jin L, Bhargava M, Joseph A, et al. Scatterfactor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. IntJCancer. 1994. 57:706-714. PMID: 8194880
    • (1994) IntJCancer. , vol.57 , pp. 706-714
    • Rosen, E.M.1    Knesel, J.2    Goldberg, I.D.3    Jin, L.4    Bhargava, M.5    Joseph, A.6
  • 14
    • 0036006814 scopus 로고    scopus 로고
    • Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
    • 11750879
    • Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002. 13:41-59. PMID: 11750879
    • (2002) Cytokine Growth Factor Rev. , vol.13 , pp. 41-59
    • Maulik, G.1    Shrikhande, A.2    Kijima, T.3    Ma, P.C.4    Morrison, P.T.5    Salgia, R.6
  • 15
    • 0034641890 scopus 로고    scopus 로고
    • A novel germ line juxtamembrane Met mutation in human gastric cancer
    • 11042681
    • Lee JH, Han SU, Cho H, Jennings B, Gerrard B, Dean M, et al. A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene. 2000. 19:4947-4953. PMID: 11042681
    • (2000) Oncogene. , vol.19 , pp. 4947-4953
    • Lee, J.H.1    Han, S.U.2    Cho, H.3    Jennings, B.4    Gerrard, B.5    Dean, M.6
  • 17
    • 33947207989 scopus 로고    scopus 로고
    • Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival
    • 17332337
    • Lutterbach B, Zeng Q, Davis LJ, Hatch H, Hang G, Kohl NE, et al. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. Cancer Res. 2007. 67:2081-2088. PMID: 17332337
    • (2007) Cancer Res. , vol.67 , pp. 2081-2088
    • Lutterbach, B.1    Zeng, Q.2    Davis, L.J.3    Hatch, H.4    Hang, G.5    Kohl, N.E.6
  • 18
    • 79961028656 scopus 로고    scopus 로고
    • Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: Their roles in tumor progression and prognostication of the patient
    • 21478826
    • Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient. Mod Pathol. 2011. 24:1146-1155. doi: 10.1038/modpathol.2011.70 PMID: 21478826
    • (2011) Mod Pathol. , vol.24 , pp. 1146-1155
    • Yamamoto, S.1    Tsuda, H.2    Miyai, K.3    Takano, M.4    Tamai, S.5    Matsubara, O.6
  • 19
    • 79959731074 scopus 로고    scopus 로고
    • Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
    • 21673683
    • Miyamoto M, Ojima H, Iwasaki M, Shimizu H, Kokubu A, Hiraoka N, et al. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma. Br J Cancer. 2011. 105:131-138. doi: 10.1038/bjc.2011.199 PMID: 21673683
    • (2011) Br J Cancer. , vol.105 , pp. 131-138
    • Miyamoto, M.1    Ojima, H.2    Iwasaki, M.3    Shimizu, H.4    Kokubu, A.5    Hiraoka, N.6
  • 20
    • 0029830062 scopus 로고    scopus 로고
    • Scatter factor expression and regulation in human glial tumors
    • 8760595
    • Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, et al. Scatter factor expression and regulation in human glial tumors. Int J Cancer. 1996. 67:248-255. PMID: 8760595
    • (1996) Int J Cancer. , vol.67 , pp. 248-255
    • Rosen, E.M.1    Laterra, J.2    Joseph, A.3    Jin, L.4    Fuchs, A.5    Way, D.6
  • 22
    • 76549109409 scopus 로고    scopus 로고
    • Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma
    • 20068147
    • Davis IJ, McFadden AW, Zhang Y, Coxon A, Burgess TL, Wagner AJ, et al. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma. Cancer Res. 2010. 70:639-645. doi: 10.1158/0008-5472. CAN-09-1121 PMID: 20068147
    • (2010) Cancer Res. , vol.70 , pp. 639-645
    • Davis, I.J.1    McFadden, A.W.2    Zhang, Y.3    Coxon, A.4    Burgess, T.L.5    Wagner, A.J.6
  • 23
    • 33847066415 scopus 로고    scopus 로고
    • TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition
    • 17283122
    • Tsuda M, Davis IJ, Argani P, Shukla N, McGill GG, Nagai M, et al. TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition. Cancer Res. 2007. 67:919-929. PMID: 17283122
    • (2007) Cancer Res. , vol.67 , pp. 919-929
    • Tsuda, M.1    Davis, I.J.2    Argani, P.3    Shukla, N.4    McGill, G.G.5    Nagai, M.6
  • 24
    • 0030885470 scopus 로고    scopus 로고
    • Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors
    • 9308731
    • Rao UN, Sonmez-Alpan E, Michalopoulos GK. Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors. Hum Pathol. 1997. 28:1066-1070. PMID: 9308731
    • (1997) Hum Pathol. , vol.28 , pp. 1066-1070
    • Rao, U.N.1    Sonmez-Alpan, E.2    Michalopoulos, G.K.3
  • 25
    • 77954747187 scopus 로고    scopus 로고
    • Functional mapping of receptor tyrosine kinases in myxoid liposarcoma
    • 20522586
    • Negri T, Virdis E, Brich S, Bozzi F, Tamborini E, Tarantino E, et al. Functional mapping of receptor tyrosine kinases in myxoid liposarcoma. Clin Cancer Res. 2010. 16:3581-3593. doi: 10.1158/1078-0432. CCR-09-2912 PMID: 20522586
    • (2010) Clin Cancer Res. , vol.16 , pp. 3581-3593
    • Negri, T.1    Virdis, E.2    Brich, S.3    Bozzi, F.4    Tamborini, E.5    Tarantino, E.6
  • 26
    • 0030070087 scopus 로고    scopus 로고
    • Over-expression of hepatocyte growth factor in human Kaposi's sarcoma
    • 8567112
    • Maier JA, Mariotti M, Albini A, Comi P, Prat M, Comogilio PM, et al. Over-expression of hepatocyte growth factor in human Kaposi's sarcoma. Int J Cancer. 1996. 65:168-172. PMID: 8567112
    • (1996) Int J Cancer. , vol.65 , pp. 168-172
    • Maier, J.A.1    Mariotti, M.2    Albini, A.3    Comi, P.4    Prat, M.5    Comogilio, P.M.6
  • 28
    • 65249122512 scopus 로고    scopus 로고
    • Novel therapeutic inhibitors of the c-met signaling pathway in cancer
    • 19318488
    • Eder JP, Vande Woude GF, Boerner SA, Lo Russo PM. Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer. Clin Cancer Res. 2009. 15:2207-2214. doi: 10.1158/1078-0432. CCR-08-1306 PMID: 19318488
    • (2009) Clin Cancer Res. , vol.15 , pp. 2207-2214
    • Eder, J.P.1    Vande Woude, G.F.2    Boerner, S.A.3    Lo Russo, P.M.4
  • 30
    • 79955897803 scopus 로고    scopus 로고
    • Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274
    • 21575221
    • Hou J, Dong J, Sun L, Geng L, Wang J, Zheng J, et al. Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. Journal of Translational Medicine. 2011. 9:64. doi: 10.1186/1479-5876-9-64 PMID: 21575221
    • (2011) Journal of Translational Medicine. , vol.9 , pp. 64
    • Hou, J.1    Dong, J.2    Sun, L.3    Geng, L.4    Wang, J.5    Zheng, J.6
  • 31
    • 84055212018 scopus 로고    scopus 로고
    • A Phase I dose-escalation study of tivantinib (ARQ 197) in adult patients with metastatic solid tumors
    • 21976535
    • Rosen LS, Senzer N, Mekhail T, Ganapathi R, Chai F, Savage RE, et al. A Phase I Dose-Escalation Study of Tivantinib (ARQ 197) in Adult Patients with Metastatic Solid Tumors. Clin Cancer Res. 2011. 17:7754-7764. doi: 10.1158/1078-0432. CCR-11-1002 PMID: 21976535
    • (2011) Clin Cancer Res. , vol.17 , pp. 7754-7764
    • Rosen, L.S.1    Senzer, N.2    Mekhail, T.3    Ganapathi, R.4    Chai, F.5    Savage, R.E.6
  • 32
    • 70350228630 scopus 로고    scopus 로고
    • Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor: C-Met-driven models of leiomyosarcoma
    • 19825800
    • Gao CF, Xie Q, Zhang YW, Su Y, Zhao P, Cao B, et al. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor: c-Met-driven models of leiomyosarcoma. Mol Cancer Ther. 2009. 8:2803-2810. doi: 10.1158/1535-7163. MCT-09-0125 PMID: 19825800
    • (2009) Mol Cancer Ther. , vol.8 , pp. 2803-2810
    • Gao, C.F.1    Xie, Q.2    Zhang, Y.W.3    Su, Y.4    Zhao, P.5    Cao, B.6
  • 33
    • 79959226237 scopus 로고    scopus 로고
    • Activated MET is a molecular prognosticatorand potential therapeutic target for malignant peripheral nerve sheath tumors
    • 21540237
    • Torres KE, Zhu Q-S, Bill K, Lopez G, Ghadimi MP, Xie X, et al. Activated MET Is a Molecular Prognosticatorand Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors. Clin Cancer Res. 2011. 17:3943-3955. doi: 10.1158/1078-0432. CCR-11-0193 PMID: 21540237
    • (2011) Clin Cancer Res. , vol.17 , pp. 3943-3955
    • Torres, K.E.1    Zhu, Q.-S.2    Bill, K.3    Lopez, G.4    Ghadimi, M.P.5    Xie, X.6
  • 34
    • 84926636387 scopus 로고    scopus 로고
    • Characterization and clinical validation of an immunohistochemical assay for Met in non-small cell lung cancer
    • Koeppen H, Januario T, Filvaroff E, Towne P, James R, Roche P, et al. Characterization and clinical validation of an immunohistochemical assay for Met in non-small cell lung cancer. Lab Invest. 2012.
    • (2012) Lab Invest.
    • Koeppen, H.1    Januario, T.2    Filvaroff, E.3    Towne, P.4    James, R.5    Roche, P.6
  • 35
    • 84868456197 scopus 로고    scopus 로고
    • Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
    • 22684217
    • Schildhaus H-U, Heukamp LC, Merkelbach-Bruse S, Riesner K, Schmitz K, Binot E, et al. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer. Mod Pathol. 2012. 25:1473-1480. doi: 10.1038/modpathol.2012.102 PMID: 22684217
    • (2012) Mod Pathol. , vol.25 , pp. 1473-1480
    • Schildhaus, H.-U.1    Heukamp, L.C.2    Merkelbach-Bruse, S.3    Riesner, K.4    Schmitz, K.5    Binot, E.6
  • 37
    • 64849095162 scopus 로고    scopus 로고
    • Genetic heterogeneity in HER2 testing in breast cancer: Panel summary and guidelines
    • 19391661
    • Vance GH, Barry TS, Bloom KJ, Fitzgibbons PL, Hicks DG, Jenkins RB, et al. Genetic Heterogeneity in HER2 Testing in Breast Cancer: Panel Summary and Guidelines. Arch Pathol Lab Med. 2009. 133:611-612. doi: 10.1043/1543-2165-133.4.611 PMID: 19391661
    • (2009) Arch Pathol Lab Med. , vol.133 , pp. 611-612
    • Vance, G.H.1    Barry, T.S.2    Bloom, K.J.3    Fitzgibbons, P.L.4    Hicks, D.G.5    Jenkins, R.B.6
  • 38
    • 84890108571 scopus 로고    scopus 로고
    • Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer
    • 24101053
    • Spigel DR, Ervin TJ, Ramlau RA, Daniel DB, Goldschmidt JH, Blumenschein GR, et al. Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2013. 31:4105-4114. doi: 10.1200/JCO.2012.47.4189 PMID: 24101053
    • (2013) J Clin Oncol. , vol.31 , pp. 4105-4114
    • Spigel, D.R.1    Ervin, T.J.2    Ramlau, R.A.3    Daniel, D.B.4    Goldschmidt, J.H.5    Blumenschein, G.R.6
  • 39
    • 84855350839 scopus 로고    scopus 로고
    • Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: Clinicopathological, immunohistochemical and molecular analysis of 66 cases
    • 21909081
    • Mentzel T, Schildhaus HU, Palmedo G, Buttner R, Kutzner H. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol. 2012. 25:75-85. doi: 10.1038/modpathol.2011.134 PMID: 21909081
    • (2012) Mod Pathol. , vol.25 , pp. 75-85
    • Mentzel, T.1    Schildhaus, H.U.2    Palmedo, G.3    Buttner, R.4    Kutzner, H.5
  • 40
    • 84926623324 scopus 로고    scopus 로고
    • Preclinical evaluation of anti-MET antibodies for immunohistochemical staining
    • 2014
    • Koeppen H, Lowe C, Rost S. Preclinical evaluation of anti-MET antibodies for immunohistochemical staining. J Clin Oncol. 2014. 32:5s, 2014(suppl;
    • (2014) J Clin Oncol. , vol.32 , pp. 5s
    • Koeppen, H.1    Lowe, C.2    Rost, S.3
  • 41
    • 84867526394 scopus 로고    scopus 로고
    • Treatment Rationale Study Design forthe MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung Cancer
    • 23063071
    • Spigel DR, Edelman MJ, Mok T, O'Byrne K, Paz-Ares L, Yu W, et al. Treatment Rationale Study Design forthe MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non-Small-Cell Lung Cancer. Clinical Lung Cancer. 2012. 13:500-504. doi: 10.1016/j.cllc.2012.05.009 PMID: 23063071
    • (2012) Clinical Lung Cancer. , vol.13 , pp. 500-504
    • Spigel, D.R.1    Edelman, M.J.2    Mok, T.3    O'Byrne, K.4    Paz-Ares, L.5    Yu, W.6
  • 42
    • 0033901252 scopus 로고    scopus 로고
    • Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal Tumors
    • 10702398
    • Wallenius V, Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, et al. Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal Tumors. Am J Pathol. 2000. 156:821-829. PMID: 10702398
    • (2000) Am J Pathol. , vol.156 , pp. 821-829
    • Wallenius, V.1    Hisaoka, M.2    Helou, K.3    Levan, G.4    Mandahl, N.5    Meis-Kindblom, J.M.6
  • 43
    • 84926675859 scopus 로고    scopus 로고
    • Predictive biomarker profiling of > 1, 900 sarcomas: Identification of potential novel treatment modalities
    • abstr10509 2014
    • Movva S, Wen W, Chen W, Millis SZ, Von Mehren M, Gatalica Z, et al. Predictive biomarker profiling of > 1, 900 sarcomas: Identification of potential novel treatment modalities. J Clin Oncol 32:5s, 2014(suppl:; abstr10509). 2014.
    • (2014) J Clin Oncol , vol.32 , pp. 5s
    • Movva, S.1    Wen, W.2    Chen, W.3    Millis, S.Z.4    Von Mehren, M.5    Gatalica, Z.6
  • 44
    • 84890254448 scopus 로고    scopus 로고
    • Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
    • 24101045
    • Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol. 2013. 31:3997-4013. doi: 10.1200/JCO.2013.50.9984 PMID: 24101045
    • (2013) J Clin Oncol. , vol.31 , pp. 3997-4013
    • Wolff, A.C.1    Hammond, M.E.H.2    Hicks, D.G.3    Dowsett, M.4    McShane, L.M.5    Allison, K.H.6
  • 45
    • 73349140213 scopus 로고    scopus 로고
    • EGFRfluorescence in situ hybridisation assay: Guidelines for application to non-small-cell lung cancer
    • 19861557
    • Varella-Garcia M, Diebold J, Eberhard DA, Geenen K, Hirschmann A, Kockx M, et al. EGFRfluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol. 2009. 62:970-977. doi: 10.1136/jcp. 2009.066548 PMID: 19861557
    • (2009) J Clin Pathol. , vol.62 , pp. 970-977
    • Varella-Garcia, M.1    Diebold, J.2    Eberhard, D.A.3    Geenen, K.4    Hirschmann, A.5    Kockx, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.